WOBURN, Mass. CutisPharma, which develops products for prescription compounding, on Wednesday announced a partnership with Rite Aid that will enable the chain to offer compounding services chainwide.
CutisPharma reported it will begin distribution of its FIRST Unit-of-Use Prescription Compounding Kits, which features pre-measured and pre-weighed components.
“Our FIRST Unit-of-Use compounding kits are user-friendly, save compounding time by over 70 percent and can be compounded by a Rite Aid pharmacist while the patient waits, increasing Rite Aid customer satisfaction and eliminating the need for an extra trip to the pharmacy,” stated Indu Muni, chairman and chief executive officer of CutisPharma.
In addition, a single National Drug Code number assigned for the entire kit for each product simplifies the third-party reimbursement process and reduces audit related adjustments, CutisPharma claimed.
According to CutisPharma research, it is estimated that approximately 30 million retail and hospital outpatient compounded prescriptions are prepared annually in the United States. About 1 percent of all prescriptions are compounded; and the U.S. market alone for compounding, at the consumer level, represents an estimated $1 billion annually.
CutisPharma currently has nine proprietary prescription compounding kits in the market, including five strengths of progesterone suppository compounding kits; two testosterone kits; one hydrocortisone kit; and one Magic Mouthwash kit.
The company plans to introduce several more compounding kits in late 2008 and 2009.